-transparent.png){kind=logo}
In five patients with inflammatory bowel disease and in two healthy control subjects retrograde spread and colonic distribution of rectally introduced sulphasalazine (SASP) enema were investigated. The SASP enema was labeled with 99mTc and imaged by a gamma camera. In all patients the SASP enema reached the inflamed portion of the colon. From 73% to 84% of the total SASP enema were fairly homogeneously distributed beyond the patients' rectum. The results suggest that patients with inflammatory bowel disease may benefit from SASP enemas even if the total colon is involved.
Related Publications
W Kruis, and
U Büll, and
J Eisenburg, and
G Paumgartner
December 1994,
Alimentary pharmacology & therapeutics,
W Kruis, and
U Büll, and
J Eisenburg, and
G Paumgartner
August 1989,
Hepato-gastroenterology,
W Kruis, and
U Büll, and
J Eisenburg, and
G Paumgartner
July 1981,
British medical journal (Clinical research ed.),
W Kruis, and
U Büll, and
J Eisenburg, and
G Paumgartner
September 1961,
British medical journal,
W Kruis, and
U Büll, and
J Eisenburg, and
G Paumgartner
May 1996,
The British journal of surgery,
W Kruis, and
U Büll, and
J Eisenburg, and
G Paumgartner
February 1986,
Diseases of the colon and rectum,
W Kruis, and
U Büll, and
J Eisenburg, and
G Paumgartner
June 1978,
Experientia,
W Kruis, and
U Büll, and
J Eisenburg, and
G Paumgartner
May 1981,
British medical journal (Clinical research ed.),
W Kruis, and
U Büll, and
J Eisenburg, and
G Paumgartner
September 2003,
Alimentary pharmacology & therapeutics,
W Kruis, and
U Büll, and
J Eisenburg, and
G Paumgartner
May 1991,
The British journal of surgery,
